SAN DIEGO -- The bioresorbable-polymer Orsiro stent continued to outperform the durable-polymer Xience in randomized data going out almost 2 years. Patients who got the Orsiro in the BIOFLOW V trial ...
BARCELONA, SPAIN —The biodegradable-polymer Orsiro sirolimus-eluting stent (Biotronik) proved superior to the durable-polymer Xience everolimus-eluting stent (Abbott Vascular) for 12-month target ...
BARCELONA, Spain—Among all the big trials airing results at the European Society of Cardiology (ESC) Congress 2017, one tiny stent—and its performance—could have slipped through the cracks. Earlier ...
NATIONAL HARBOR, MD—At 3 years, the bioresorbable-polymer Orsiro stent maintains an advantage over the durable-polymer Xience, according to new data from the BIOFLOW V study. Compared with PCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results